Table 3 Between group differences for ultrasonographic features at baseline and 4th week.
Grouping variable | Median ± I.Q. R | Mean rank | Mann–Whitney U-test, p-value | |
|---|---|---|---|---|
Baseline tendon thickness, mm | CPT | 7.65 ± .40 | 46.58 | 1060.000, p = 0.496 |
UG-DN + CPT | 7.70 ± .20 | 50.42 | ||
Fourth week tendon thickness, mm | CPT | 7.0 ± .20 | 63.05 | 453.500, p = 0.000 |
UG-DN + CPT | 6.1 ± 1.1 | 33.95 |
Grouping variable | Total frequency (%) | |||
|---|---|---|---|---|
CPT frequency (%) | UG-DN + CPT frequency (%) | |||
Tendon structure through echogenicity at baseline | Normal structure | 8 (8.3%) | 8 (8.3%) | 16 (16.7%) |
Light structural change | 21 (21.9%) | 19 (19.8%) | 40 (41.7%) | |
Moderate structural change | 16 (16.7%) | 17 (17.7%) | 33 (34.4%) | |
Severe structural change | 3 (3.1%) | 4 (4.2%) | 7 (7.3%) | |
Tendon structure through echogenicity at 4th week | Normal structure | 14 (14.6%) | 22 (22.9%) | 36 (37.5%) |
Light structure change | 21 (21.9%) | 16 (16.7%) | 37 (38.5%) | |
Moderate structural change | 13 (13.5%) | 10 (10.4%) | 23 (24.0%) | |
Z-score, p-value | − 5.038, ≤ 0.001 | − 1.930, 0.054 | ||
Neovascularization at baseline | No neovascularization | 3 (3.1%) | 2 (2.1%) | 5 |
Mild neovascularization | 12 (12.5%) | 10 (10.4%) | 22 | |
Moderate neovascularization | 30 (31.3%) | 32 (33.3%) | 62 | |
Severe | 3 (3.1%) | 4 (4.2%) | 7 (7.3%) | |
Neovascularization at 4th week | No neovascularization | 3 (3.1%) | 18 (18.8%) | 21 (21.9%) |
Mild neovascularization | 21 (21.9%) | 17 (17.7%) | 38 (39.6%) | |
Moderate neovascularization | 22 (22.9%) | 12 (12.5%) | 34 (35.4%) | |
Severe neovascularization | 2 (2.1%) | 1 (1.0%) | 3 (3.1%) | |
Z-score, p-value | − 4.949, ≤ 0.001 | − 3.162, 0.002 | ||
